glp-1 agonist common side effects Gastrointestinal (GI) of Receptor Agonists —Semaglutide —Liraglutide —Dulaglutide The expanding role of GLP-1

Pharmacological treatment of hyperglycemia in type 2 diabetes

Previous clinical trials have confirmed that GLP-1RAs have certain protective effects on the cardiovascular system, microvasculature, and kidneys [39]

The pattern of association reflected that of the main intention-to-treat analysis, with point estimates less than 1.0 in the as-treated analyses with a one year lag and with increased hazard ratios in the as-treated analyses restricted to the first year after starting treatment

A meta-analysis has indeed highlighted that only about 5060% of patients with diabetes adhere to antidiabetic therapy [69], with a significant impact on quality of life and life expectancy

Unlike SGLT-2 inhibitors, GLP-1 receptor agonists can be used in patients with advanced-stage CKD or ESKD